TFDA-2024-0051-V051
Type II variation for application TFDA-2024-0051. Type II variation: Container Closure Change for Lorlatenilib — critical change
Variation Number
TFDA-2024-0051-V051
Type
Type II
Application
Change
Status
Failed
Fee
€54,297
Submitted
—
Approved
—
Description
Type II variation: Container Closure Change for Lorlatenilib — critical change